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Abstract
Purpose Initial genetic alterations in the development of childhood leukemia occur in utero or before conception; both 
genetic and environmental factors are suspected to play a role. We aimed to investigate the associations between childhood 
leukemia and perinatal characteristics including birth order, birth interval to older siblings, parental age, birth weight, and 
multiple birth.
Methods We identified cases diagnosed between 1981 and 2015 and born in Switzerland between 1969 and 2015 from 
the Swiss Childhood Cancer Registry and randomly sampled five controls per case from national birth records matched on 
date of birth, sex, and municipality of residence at birth. We used conditional logistic regression to investigate associations 
between perinatal characteristics and leukemia at ages 0–15 and 0–4 years, and the subtypes acute lymphoblastic leukemia 
(ALL) and acute myeloid leukemia (AML).
Results The study included 1,403 cases of leukemia. We observed increased risks associated with high birth weight (adjusted 
OR 1.37, 95% CI 1.12–1.69) and multiple birth (1.89, 1.24–2.86). These associations were similar for ALL and stronger for 
leukemia at ages 0–4 years. For AML, we observed an increased risk for higher birth order (3.08, 0.43–22.03 for fourth or 
later born children). We found no associations with other perinatal characteristics.
Conclusion This register-based case–control study adds to the existing evidence of a positive association between high birth 
weight and risk of childhood leukemia. Furthermore, it suggests children from multiple births are at an increased risk of 
leukemia.
Keywords Epidemiology · Birth weight · Maternal age · Paternal age · Parity · Twins
Introduction
Both genetic and environmental factors are suspected to play 
a role in the etiology of childhood leukemia [1, 2]. Estab-
lished risk factors include ionizing radiation in medium to 
high doses and certain inherited disorders such as Li Frau-
meni syndrome or chromosomal abnormalities such as 
Down syndrome, yet these account for only a fraction of 
cases [2, 3]. Suspected environmental risk factors include 
low level ionizing radiation [4, 5], air pollution [6], ben-
zene [7], exposure to infections [8, 9], agricultural pesticides 
[10, 11], or parental occupational exposures [12, 13]. There 
is compelling evidence that childhood leukemia originates 
early in life with initial genetic alterations occurring in utero 
or before conception [1, 14].
In view of a possible early origin of childhood leuke-
mia, many studies have investigated associations between 
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perinatal characteristics and later development of disease. 
A number of studies found decreased risks of acute lympho-
blastic leukemia (ALL) for children with older siblings, sup-
porting the hypothesis that increased exposure to infections 
may be protective [15–19]. However, several large cohort 
studies found no evidence of such an effect [20–23]. Any 
protective effect of high birth order might be mediated by 
the birth interval between a newborn and older siblings yet 
only few studies have accounted for this with mixed results 
[22, 24, 25]. Higher parental age at birth was also found 
to be associated with the risk of both ALL and acute mye-
loid leukemia (AML) in recent analyses of pooled datasets 
and meta-analyses [26–28]. High birth weight is an estab-
lished risk factor for childhood leukemia and ALL [29–32]. 
Recent studies have consistently shown positive associations 
between high birth weight relative to gestational age [33]. 
Finally, some early studies suggested that multiple birth may 
protect against later development of childhood leukemia 
[34, 35]. However, these findings could not be reproduced 
in recent studies that consistently adjusted for birth weight 
[20, 36].
We aimed to investigate the associations between child-
hood leukemia and perinatal characteristics in a nation-
wide register-based case–control study in Switzerland. We 
hypothesized that leukemia risk would be positively associ-
ated with higher maternal and paternal age, and negatively 
associated with higher birth order and a shorter birth interval 
to the next older sibling. In contrast to an earlier Swiss study 
of birth characteristics and childhood leukemia, which was 
based on partially overlapping data [19], this study is based 




We identified all primary diagnoses of leukemia registered in 
the Swiss Childhood Cancer Registry (SCCR) between 1981 
and 2015 in children who were aged 0–15 years at diagnosis 
and had been born in Switzerland between 1969 and 2015. 
The SCCR is a nation-wide population-based cancer registry 
recording cancers in children and adolescents since 1976. 
It includes an estimated 91% of all diagnoses since the late 
1980s, and an estimated 95% since the mid-1990s [37]. We 
used probabilistic linkage to match SCCR cases with cor-
responding birth records from the vital statistics of the Swiss 
Federal Statistical Office (FSO). The linkage was based on 
first names, date of birth, sex, municipality of residence at 
birth, and date of birth of both parents and was performed 
with G-link 2.3 (Statistics Canada, Ottawa, Ontario).
We randomly sampled five controls (birth records not 
linked to a cancer case) per case without replacement, 
matched on date of birth (± 6 months), sex, and municipality 
of residence of the mother at birth. We matched on munici-
pality to reduce potential confounding by spatially varying 
risk factors. In some small municipalities, the number of 
eligible controls was smaller than five, in which case we 
selected controls from adjacent municipalities (first-order 
neighbors). This occurred for 3.0% of all controls.
Outcomes and perinatal characteristics
We separately investigated the following outcomes based on 
the International Classification of Childhood Cancers, Third 
Edition (ICCC-3) [38]: leukemia (ICCC-3 main group-
I), lymphoid leukemia (I.a) and acute myeloid leukemias 
(AML, I.b). Because chronic lymphocytic leukemia (CLL) 
(included in I.a) is exceedingly rare in children, we refer to 
ICCC-3 subgroup I.a as ALL. There were no cases of CLL 
in our study sample. We ran separate analyses for children 
aged 0–15 years, and 0–4 years for leukemia given the char-
acteristic peak incidence among children under 5 years of 
age.
We investigated associations with the following perina-
tal characteristics: birth order in the sequence of live births 
by the same mother (first born, second, third, or fourth or 
later born), birth interval to the next older sibling (first born, 
1–2 years, 3–4 years, or 5+ years), age of the mother and 
of the father at date of birth (< 25, 25–29, 30–34, 35–39, 
40+ years), birth weight (< 2,500, 2,500–3,999, ≥ 4,000 g), 
multiple birth (singleton or multiple birth), and national-
ity of the mother (Swiss or other). We calculated pairwise 
Spearman’s rank correlations between the included birth 
characteristics.
We extracted all data on perinatal characteristics for both 
cases and controls from their birth records. In Swiss birth 
records, birth order and date of birth of the last previous 
birth are recorded only for births by married mothers, which 
accounted for 90.7% of total births between 1969 and 2015. 
Parental age and birth interval to the next older sibling were 
calculated as completed life years at the index child’s date of 
birth. Paternal age and the date of birth of the last previous 
birth were recorded only since 1979, and between 1979 and 
1986 only year of birth instead of date of birth was recorded 
for mothers and fathers. For these years, we randomly attrib-
uted a specific date of the year of birth to calculate paren-
tal age. For multiple births, birth order was recorded in the 
order of actual births, i.e., in twins the later born is one rank 
higher than the earlier born. The birth interval to the next 
older sibling though was set to be the same for every child of 
a multiple birth and calculated as for a singleton birth, i.e., 
the number of years since the last previous birth if a woman 
had already given birth before and 0 otherwise.
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Statistical analysis
We used conditional logistic regression to investigate asso-
ciations between leukemia, ALL, and AML and perinatal 
characteristics conditioning on the matched case–control 
sets. We fitted univariable models for every perinatal char-
acteristic separately and multivariable models including all 
characteristics simultaneously to obtain crude and adjusted 
odds-ratios (OR) and 95% confidence intervals (CI). Likeli-
hood ratio tests were performed to compare models with and 
without a given perinatal characteristic.
For leukemia and ALL we tested for possible interactions 
between pairs of perinatal characteristics that have recently 
been reported in the literature using likelihood ratio tests. 
Specifically, we tested for interactions between birth order 
(dichotomized first-born vs. later-born) and age of the father 
as well as between birth order and birth weight [39]. We also 
ran separate conditional logistic regression models including 
birth weight as a continuous variable and as a 7-level cat-
egorical variable (septiles) to investigate a possible U-shape 
of the association for AML [29, 31].
In sensitivity analyses, we (i) included only one (ran-
domly sampled) twin from every twin pair of children with 
concordant leukemia; and (ii) excluded case–control sets of 
cases with trisomy 21.
All statistical analyses were performed using the R 
language for statistical computing version 3.6.0 [40] and 
STATA 15.1 (StataCorp, College Station, TX, USA).
Results
We identified 1,623 children diagnosed with leukemia at 
age 0–15 years during 1981–2015 and born in Switzerland 
between 1969 and 2015. Of these, 225 (14%) could not be 
linked with a birth record, leaving 1,403 cases for analysis. 
Among the included cases, 1,144 (82%) were diagnosed 
with ALL and 179 (13%) with AML (Table 1). Of all leu-
kemia cases, 576 (41%) were first-born, whereas 57 (4.1%) 
were fourth or later births by the same mother (Table S1 in 
the online supplementary material). Among cases, the preva-
lence of high birth weight (≥ 4000 g, 10.5% vs. 8.2%) and 
multiple birth (3.5% vs. 2.2%) was higher than among con-
trols; 49 cases were born as part of a twin pair (Table S1). 
We found strong positive correlations between birth order 
and interval to next older sibling and between maternal and 
paternal age, and a negative correlation between multiple 
birth and birth weight (Fig. S1).
We observed an increased risk of childhood leukemia 
at age 0–15 years among children with high birth weight 
compared to normal weight (adjusted odds ratio [OR] 
1.37, 95% confidence interval [CI] 1.12–1.69) (Table 2). 
The adjusted model also indicated a reduced risk for low 
birth weight (adjusted OR 0.77, CI 0.56–1.05) (Table 2). 
We also found evidence of an increased risk of develop-
ing leukemia among children from multiple births com-
pared to singletons which became stronger after adjusting 
for other covariates (adjusted OR 1.89, CI 1.24–2.86). 
Although there was no evidence for an association with 
maternal age (p value from LR test 0.71), the estimated 
risk was lowest for the youngest age category (< 25 years, 
reference) (Table 2). By contrast, we found no evidence 
of an association with other perinatal characteristics (p 
values of LR tests all > 0.4; Table 2).
Results for ALL at 0–15 years (Table 3) and leukemia 
under 5 years of age (Table 4) were broadly similar. Strong 
evidence for an increased risk of ALL at 0–15 years was 
again observed in the adjusted models for high birth weight 
(adjusted OR 1.50, CI 1.19–1.87) and being part of a mul-
tiple birth (adjusted OR 1.82, CI 1.15–2.88) (Table 3). The 
association with multiple birth was stronger for leukemia 
diagnosed under 5  years of age (adjusted OR 2.23, CI 
1.32–3.76) than for ALL at 0–15 years (Table 4).
Results for AML at 0–15 years of age were rather dif-
ferent except for multiple birth, which was also associated 
with an increased risk although the evidence was weaker 
(adjusted OR 2.44, CI 0.55–10.77) (Table 5). There was evi-
dence of an increased risk associated with higher birth order 
(p LR test = 0.04 in the adjusted model) (Table 5). Adjusted 
ORs were 1.76 (CI 0.25–12.22) and 3.08 (CI 0.43–22.03) 
in third-born and fourth- or later-born children, respectively. 
By contrast, there was little evidence of an association for 
the other birth characteristics (Table 5).
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 Cancer Causes & Control
1 3
Testing for interactions between perinatal character-
istics, we found weak evidence of an interaction between 
birth order (dichotomized first-born vs. later-born) and 
birth weight in the adjusted models for ALL diagnosed at 
0–15 years (p LR test = 0.049) and leukemia under 5 years 
of age (p LR test = 0.073) but not for leukemia overall (p 
LR test = 0.20) (Tables S3–S5). Estimated interaction terms 
indicted that, among children with high or low birth weight, 
those born second or later had lower risks compared to first-
borns (Tables S3–S5). By contrast, we found no evidence 
of an interaction between birth order and age of the father 
for any of the three outcomes (p LR tests all > 0.5; results 
not shown).
Assessing the functional shape of the association with 
birth weight, the adjusted model using septiles of birth 
weight as a categorical variable showed no indication of a 
monotonous increase in ALL risk (p LR test = 0.13; Fig. 1). 
A positive linear association was observed though when 
including birth weight as a continuous variable with an esti-
mated adjusted OR per 1000 g positive difference in birth 
weight of 1.16 (CI 1.01–1.33). This trend seems to be driven 
by children with high birth weights (highest septile) (Fig. 1). 
For AML, the adjusted model using septiles of birth weight 
showed weak evidence on an association (p LR test = 0.06; 
Fig. 1), however, there was no indication of a linear trend 
for birth weight as a continuous variable (adjusted OR 0.99, 
0.69–1.41).
In sensitivity analyses, we included only one twin from 
each of the four twin pairs with concordant diagnoses of leu-
kemia we identified in the SCCR. In this analysis, the odds 
ratio for being part of a multiple birth was slightly reduced 
compared to the main analysis (adjusted OR 1.80, 1.18–2.75) 
but the other results remained similar (Table S6). Excluding 
cases with trisomy 21 (n = 43) reduced the estimated OR of 
leukemia for mothers of the age group ≥ 40 years (adjusted 
OR 0.85, 0.49–1.48) but left other estimates unchanged 
Table 2  Associations between perinatal characteristics and childhood leukemia, diagnosed at age 0–15 years
a Odds ratio of raw conditional logistic regression models
b 95% confidence interval
c p value of likelihood ratio test comparing model with and without a given perinatal characteristic
d Odds ratio of conditional logistic regression models adjusting for birth order, interval to next older sibling, age of mother, age of father, birth 
weight, multiple birth, and nationality of mother
Exposure Categories Cases Crude  ORa 95%  CIb p  valuec Cases Adjusted  ORd 95%  CIb p  valuec
Birth order First born 576 1.00 0.91 554 1.00 0.98
Second 474 1.00 (0.88–1.14) 458 1.09 (0.57–2.10)
Third 172 1.06 (0.88–1.28) 166 1.12 (0.57–2.22)
Fourth or later 57 1.07 (0.79–1.46) 55 1.13 (0.54–2.34)
Interval to next older sibling First born 570 1.00 0.52 569 1.00 0.57
1–2 years 400 1.00 (0.86–1.15) 398 0.89 (0.46–1.72)
3–4 years 159 0.96 (0.80–1.17) 159 0.87 (0.44–1.70)
5+ years 108 1.18 (0.93–1.48) 107 1.05 (0.52–2.09)
Age of mother  < 25 years 228 1.00 0.65 188 1.00 0.71
25–29 years 486 1.08 (0.91–1.28) 427 1.10 (0.89–1.35)
30–34 years 467 1.13 (0.95–1.35) 426 1.19 (0.94–1.51)
35–39 years 186 1.09 (0.88–1.36) 165 1.16 (0.87–1.56)
40+ years 36 1.25 (0.84–1.85) 27 1.16 (0.70–1.91)
Age of father  < 25 years 80 1.00 0.97 80 1.00 0.66
25–29 years 305 0.93 (0.71–1.22) 303 0.86 (0.64–1.15)
30–34 years 448 0.93 (0.71–1.21) 440 0.79 (0.58–1.08)
35–39 years 281 0.95 (0.72–1.25) 273 0.79 (0.56–1.09)
40+ years 140 0.98 (0.71–1.34) 137 0.81 (0.56–1.17)
Birth weight  < 2,500 g 71 0.94 (0.73–1.23) 0.022 60 0.77 (0.56–1.05) 0.002
2,500–3,999 g 1,141 1.00 1,034 1.00
 ≥ 4,000 g 148 1.31 (1.08–1.59) 139 1.37 (1.12–1.69)
Multiple birth Singleton 1,354 1.00 0.004 1,189 1.00 0.004
Multiple 49 1.68 (1.20–2.36) 44 1.89 (1.24–2.86)
Nationality of mother Swiss 1,039 1.00 0.23 911 1.00 0.41
Other 361 0.92 (0.80–1.06) 322 0.94 (0.80–1.10)
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(Table S7). Following the suggestion of a reviewer, we 
repeated the main analyses excluding case–control sets of 
cases from multiple births. Results from these analyses were 
very similar to the main analysis (Tables S8–S11).
Discussion
Main findings
This register-based case–control study showed strong evi-
dence of an increased risk of leukemia among children with 
high birth weight (≥ 4,000 g) and children from multiple 
births. These associations were similar for ALL and stronger 
for children diagnosed under the age of 5 years. For AML, 
there was little evidence for associations with birth weight 
and multiple births, although including birth weight as a 
7-level categorical variable (septiles) was suggestive of a 
non-linear association, which by visual inspection is compat-
ible with a U-shape (Fig. 1). However, we did find evidence 
of an increased risk of AML in third or later-born children 
compared to first-born children. There was little evidence 
of an association for the other investigated birth character-
istics, although estimated ORs for leukemia and ALL in the 
offspring of mothers belonging to older age groups were 
consistently higher than in those of mothers aged less than 
25 years.
Results in the context of previous studies
Our findings are compatible with the results of our previous 
study [19] using partially overlapping data from the SCCR. 
That study found an increased risk of ALL for higher age 
of the mother and a weak protective effect of having older 
siblings in the same household in children under 5 years 
of age but not in older children. Compared to the present 
Table 3  Associations between perinatal characteristics and ALL, diagnosed at age 0–15 years
a Odds ratio of raw conditional logistic regression models
b 95% confidence interval
c p value of likelihood ratio test comparing model with and without a given perinatal characteristic
d Odds ratio of conditional logistic regression models adjusting for birth order, interval to next older sibling, age of mother, age of father, birth 
weight, multiple birth, and nationality of mother
Exposure Categories Cases Crude  ORa 95%  CIb p  valuec Cases Adjusted  ORd 95%  CIb p  valuec
Birth order First born 468 1.00 0.73 448 1.00 0.67
Second 397 1.07 (0.93–1.24) 383 1.12 (0.53–2.36)
Third 135 1.01 (0.82–1.25) 130 1.02 (0.47–2.21)
Fourth or later 43 0.92 (0.65–1.31) 41 0.93 (0.40–2.13)
Interval to next older sibling First born 461 1.00 0.71 460 1.00 0.72
1–2 years 331 1.03 (0.88–1.21) 329 0.92 (0.44–1.95)
3–4 years 128 1.00 (0.80–1.24) 128 0.90 (0.42–1.92)
5+ years 86 1.16 (0.90–1.50) 85 1.07 (0.49–2.34)
Age of mother  < 25 years 182 1.00 0.37 147 1.00 0.24
25–29 years 393 1.10 (0.91–1.34) 345 1.15 (0.90–1.45)
30–34 years 386 1.21 (1.00–1.48) 356 1.34 (1.03–1.75)
35–39 years 155 1.11 (0.87–1.41) 135 1.25 (0.90–1.73)
40+ years 28 1.25 (0.80–1.95) 19 1.08 (0.61–1.94)
Age of father  < 25 years 65 1.00 0.95 65 1.00 0.68
25–29 years 241 0.93 (0.68–1.26) 239 0.84 (0.61–1.16)
30–34 years 373 0.99 (0.74–1.33) 371 0.81 (0.58–1.14)
35–39 years 229 0.96 (0.71–1.31) 222 0.76 (0.53–1.09)
40+ years 107 0.93 (0.66–1.32) 105 0.76 (0.50–1.16)
Birth weight  < 2,500 g 57 0.95 (0.71–1.27) 0.006 50 0.83 (0.59–1.17) 0.001
2,500–3,999 g 923 1.00 833 1.00
 ≥ 4,000 g 126 1.42 (1.15–1.75) 119 1.50 (1.19–1.87)
Multiple birth Singleton 1,105 1.00 0.027 966 1.00 0.013
Multiple 39 1.55 (1.07–2.25) 36 1.82 (1.15–2.88)
Nationality of mother Swiss 850 1.00 0.34 745 1.00 0.60
Other 291 0.93 (0.79–1.08) 257 0.95 (0.80–1.14)
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study, that study was based on a smaller sample comprising 
425 children with ALL and did not include data on multiple 
births and birth weight.
Our current findings on birth weight concur with the 
literature that has established high birth weight as a risk 
factor for several childhood cancers including leukemia. 
Several pooled and meta-analyses have observed a linear 
trend between birth weight and childhood leukemia or 
ALL, or both [29–32, 41]. Our model estimate for ALL 
for birth weight as a continuous linear term (adjusted OR 
1.16/1,000-g increase in birth weight) matched these find-
ings closely (pooled OR 1.18, CI 1.13–1.23 [29]; pooled OR 
1.14, CI 1.08–1.20 [30]). Accelerated fetal growth might 
serve as explanation as suggested by a recent pooled analy-
sis by the Childhood Leukemia International Consortium 
(CLIC) showing a strong consistent positive association with 
increased risk of ALL [33]. However, we lacked information 
on gestational age (which has been collected in Swiss birth 
records only since 2006) and could thus not account for this. 
By contrast, the evidence on the association between birth 
weight and childhood AML is more heterogeneous with both 
pooled and meta-analyses suggesting a U-shaped association 
[17, 29, 31]. However, a recent CLIC study found a positive 
association for AML with high birth weight and with being 
large-for-gestational-age but no indication of a U-shaped 
association [42].
Regarding the association between parental age and 
ALL, our findings are compatible with the results of a 
meta-analysis of 77 studies [26] and a recent CLIC study 
[27] showing a monotonically increasing risk with higher 
age of the mother that was stronger among children under 
5 years of age. The same study also observed an increased 
risk of ALL for higher age of the father. However, two recent 
large register-based studies in Sweden and California [20, 
43], like our study, found no evidence of such an associa-
tion. For AML, our findings were suggestive of a lower risk 
Table 4  Associations between perinatal characteristics and childhood leukemia, diagnosed at age 0–4 years
a Odds ratio of raw conditional logistic regression models
b 95% confidence interval
c p value of likelihood ratio test comparing model with and without a given perinatal characteristic
d Odds ratio of conditional logistic regression models adjusting for birth order, interval to next older sibling, age of mother, age of father, birth 
weight, multiple birth, and nationality of mother
Exposure Categories Cases Crude  ORa 95%  CIb p  valuec Cases Adjusted  ORd 95%  CIb p  valuec
Birth order First born 327 1.00 0.32 325 1.00 0.71
Second 241 0.87 (0.73–1.04) 239 0.94 (0.40–2.22)
Third 88 0.94 (0.72–1.22) 87 0.95 (0.38–2.35)
Fourth or later 25 0.74 (0.47–1.15) 25 0.72 (0.27–1.92)
Interval to next older sibling First born 335 1.00 0.23 334 1.00 0.81
1–2 years 206 0.83 (0.68–1.00) 205 0.87 (0.37–2.05)
3–4 years 83 0.86 (0.66–1.12) 83 0.91 (0.38–2.21)
5+ years 54 0.99 (0.71–1.36) 54 1.02 (0.41–2.56)
Age of mother  < 25 years 112 1.00 0.80 95 1.00 0.32
25–29 years 252 1.01 (0.79–1.29) 227 1.11 (0.83–1.49)
30–34 years 260 1.12 (0.87–1.43) 237 1.34 (0.96–1.86)
35–39 years 115 1.10 (0.82–1.48) 101 1.41 (0.94–2.10)
40+ years 23 1.19 (0.72–1.96) 16 1.12 (0.57–2.17)
Age of father  < 25 years 38 1.00 0.94 38 1.00 0.75
25–29 years 162 1.01 (0.68–1.49) 160 0.94 (0.62–1.43)
30–34 years 253 1.03 (0.70–1.50) 246 0.89 (0.57–1.38)
35–39 years 156 0.96 (0.64–1.42) 150 0.79 (0.49–1.26)
40+ years 85 1.08 (0.70–1.68) 82 0.90 (0.53–1.52)
Birth weight  < 2,500 g 49 1.20 (0.86–1.65) 0.10 40 0.95 (0.65–1.39) 0.032
2,500–3,999 g 631 1.00 562 1.00
 ≥ 4,000 g 78 1.30 (1.00–1.70) 74 1.47 (1.11–1.95)
Multiple birth Singleton 728 1.00  < 0.001 647 1.00 0.004
Multiple 34 2.21 (1.45–3.37) 29 2.23 (1.32–3.76)
Nationality of mother Swiss 552 1.00 0.60 488 1.00 0.81
Other 209 0.95 (0.79–1.15) 188 1.03 (0.83–1.26)
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Table 5  Associations between perinatal characteristics and AML, diagnosed at age 0–15 years
a Odds ratio of raw conditional logistic regression models
b 95% confidence interval
c p value of likelihood ratio test comparing model with and without a given perinatal characteristic
d Odds ratio of conditional logistic regression models adjusting for birth order, interval to next older sibling, age of mother, age of father, birth 
weight, multiple birth, and nationality of mother
Exposure Categories Cases Crude  ORa 95%  CIb p  valuec Cases Adjusted  ORd 95%  CIb p  valuec
Birth order First born 72 1.00 0.006 71 1.00 0.037
Second 53 0.72 (0.49–1.05) 52 0.95 (0.15–6.01)
Third 29 1.39 (0.84–2.30) 28 1.76 (0.25–12.22)
Fourth or later 10 2.73 (1.18–6.32) 10 3.08 (0.43–22.03)
Interval to next older sibling First born 73 1.00 0.52 73 1.00 0.74
1–2 years 47 0.83 (0.55–1.24) 47 0.75 (0.12–4.70)
3–4 years 24 0.93 (0.56–1.55) 24 0.78 (0.12–5.10)
5+ years 17 1.33 (0.71–2.51) 17 1.11 (0.16–7.65)
Age of mother  < 25 years 25 1.00 0.27 22 1.00 0.15
25–29 years 74 1.46 (0.89–2.40) 66 1.80 (0.95–3.42)
30–34 years 54 0.99 (0.59–1.67) 48 1.20 (0.59–2.46)
35–39 years 20 1.31 (0.67–2.55) 19 1.37 (0.56–3.39)
40+ years 6 1.74 (0.61–5.01) 6 2.90 (0.72–11.64)
Age of father  < 25 years 10 1.00 0.13 10 1.00 0.17
25–29 years 47 1.04 (0.48–2.22) 47 0.73 (0.31–1.76)
30–34 years 53 0.68 (0.32–1.44) 51 0.45 (0.18–1.12)
35–39 years 31 0.76 (0.34–1.71) 30 0.48 (0.17–1.31)
40+ years 23 1.30 (0.55–3.12) 23 0.68 (0.23–2.03)
Birth weight  < 2,500 g 7 0.64 (0.29–1.46) 0.29 6 0.41 (0.14–1.25) 0.18
2,500–3,999 g 156 1.00 143 1.00
 ≥ 4,000 g 13 0.69 (0.37–1.29) 12 0.76 (0.39–1.51)
Multiple birth Singleton 174 1.00 0.39 156 1.00 0.24
Multiple 5 1.61 (0.57–4.60) 5 2.44 (0.55–10.77)
Nationality of mother Swiss 128 1.00 0.77 113 1.00 0.97
Other 51 1.06 (0.73–1.54) 48 1.01 (0.66–1.55)
Fig. 1  Association between birth weight and ALL and AML, diag-
nosed at age 0–15 years. Adjusted odds ratios (black dots) and 95% 
confidence intervals for septiles of birth weight compared to the mid-
septile (the points are plotted against mean birth weight within sep-
tiles); Odds ratio (blue line) of birth weight as a continuous variable 
in an otherwise identical conditional logistic regression model. (Color 
figure online)
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among children of young mothers but a higher risk among 
children of young fathers, though the evidence was weak. 
This is compatible with findings of the meta-analysis which 
observed an increased risk of AML in the offspring of the 
youngest fathers only [26]. However, a recent pooled analy-
sis by CLIC observed no association between paternal age 
and risk of AML [28].
Higher birth order was found to be associated with 
reduced risk of ALL in a number of studies [16–18, 24]. 
However, results from cohort studies were mostly incon-
clusive [20–23]. A meta-analysis by the CLIC consortium 
reported a slight protective effect of higher birth order but 
with significant heterogeneity between individual studies 
[44]. More recently, the International Childhood Cancer 
Cohort Consortium (I4C) reported a protective effect for 
higher birth order that was based on only 185 cases of ALL 
[39]. For AML, our study results are consistent with a num-
ber of studies including a review reporting some evidence of 
increased risks for higher birth order [45]. Only few studies 
also looked at the actual birth interval between siblings. Two 
studies reported increased risks for ALL associated with 
birth intervals larger than 3 and 5 years, respectively [22, 
46], while other studies, like ours, found no evidence of an 
association [25, 47] or a protective effect for birth intervals 
of less than 5 years [24]. None of these studies reported 
evidence of any association for AML. Our results also sup-
port a recent report that the effect of birth order on risk of 
ALL might be modified by birth weight [39]. Specifically, 
for children with low birth weight (< 2,500 g), the risk of 
ALL under 5 years was reduced in our study among later-
born compared to first-born children.
This is the first study to report evidence of an increased 
risk of childhood leukemia and ALL in children from mul-
tiple births. While a number of studies of perinatal char-
acteristics have included multiple birth as a covariate in 
multivariate models, no large cohort or case–control study 
has reported evidence of any association with childhood 
leukemia [20, 25, 48]. Studies specifically comparing twins 
with singletons have reported either a reduced leukemia risk 
for same sex twins [34] or found no evidence of an effect on 
leukemia risk [36].
Strengths and weaknesses
Because we identified cases from a population-based cancer 
registry of high coverage and sampled controls from national 
birth records, the risk of selection bias in our study is lim-
ited. Information on birth characteristics was obtained from 
the same source, namely the birth records, for cases and 
controls at the time of birth, suggesting that our study is free 
of recall bias or differential misclassification. We were able 
to include leukemia cases diagnosed during a period of over 
three decades, allowing us to achieve a sample size that is 
comparable with the most recent European case–control or 
cohort studies. Matching by date of birth and municipality of 
residence of the mother at time of birth should have reduced 
the potential risk of confounding by spatial or temporal vari-
ation in environmental risk factors, such as traffic-related 
air-pollution [6, 49], background ionizing radiation [5, 50], 
or agricultural pesticides [10, 11].
Probabilistic record linkage of cases with their birth 
records may have resulted in some misclassifications of the 
outcomes. However, this risk appears small as the outcomes 
considered are rare and the linkage led to non-ambiguous 
matches in the overwhelming majority of cases. A consider-
able proportion of children had missing data for birth order 
(10%), birth interval to the next older sibling (13%), and 
age of the father (11%) and excluding these children may 
have introduced some selection bias if data were not missing 
at random [51]. This risk may be compounded by the fact 
that in the birth records, due to administrative procedures 
of record keeping, parity of the mother is recorded only for 
married but not for single or divorced women. However, the 
number of births to unmarried parents made up less than 
10% of all births in the national birth registry and rates of 
missingness varied only minimally between cases of the dif-
ferent outcomes and controls (Table S2). Moreover, we did 
not require controls to be living in Switzerland at the time 
of the cases’ diagnosis (a requirement for cases), which may 
have introduced selection bias. The direction of this possible 
bias is unclear though. Finally, in an observational study, we 
cannot exclude residual confounding by risk factors we did 
not have information on. In particular, we had no informa-
tion on certain perinatal characteristics of interest such as 
gestational age [33], mode of delivery [52], or use of artifi-
cial reproduction technologies [53].
Interpretation
It is unclear what might explain the observed association 
between multiple birth and childhood leukemia in our study. 
Newborns from multiple births typically have lower birth 
weight. Early studies reporting a reduced risk were often 
small and did not (consistently) control for birth weight 
(reviewed in [35]). Another study of any childhood cancers 
(all diagnostic groups, not only leukemias) in twins that par-
tially controlled for birth weight found a reduced overall 
risk but noted an excess of cases among twins with birth 
weight of 3 kg and higher [35]. In our study, we adjusted 
for birth weight, and low birth weight was associated with 
a decreased risk of leukemia, and so cannot explain an 
increased risk among children from multiple births. More-
over, it is known, that if one twin has been diagnosed with 
childhood leukemia, the other has an increased risk of also 
developing the disease, allegedly due to the intra-placental 
transfer of pre-leukemic clones from one fetus to the other 
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[1, 54]. However, this could not account for the observed 
effect either as the sensitivity analysis in which we excluded 
one twin from each of the concordant pairs has shown. This 
analysis simulates a situation, in which the in utero exposure 
to a pre-leukemic clone has no effect because the second 
twin, by being excluded from the analysis, is considered 
to have been unaffected by leukemia. If the in utero trans-
fer of a pre-leukemic clone was the main causal pathway 
underlying the increased leukemia risk of twins, the risk 
among twins in this analysis should resemble that of sin-
gletons. Another possible explanation might be an adverse 
event of medical interventions associated with multiple 
birth such as fertility treatments, medically assisted repro-
duction (MAR) [53, 55], and prelabour cesarean delivery 
[52]. In the FSO birth records, the proportion of multiple 
births among total births increased almost linearly with 
maternal age, from 1.6% among mothers aged 25 years or 
younger to 4.2% among those aged 40 years and above. We 
lacked data on individual use of MAR but, according to the 
FSO, the number of children conceived by MAR has risen 
from 910 in 2002 to 2,020 in 2015, making up 2.3% of total 
live births that year. Moreover, the proportion of multiple 
births among all children conceived by MAR has fluctu-
ated between 15.5% and 22.8% over this period. In order 
to address the possibility that multiple birth may be associ-
ated with leukemia because in recent years it has become 
almost a marker for MAR, we carried out an ex post analy-
sis subsetting our data by decade (1980–1989, 1990–1999, 
2000–2009). We found that compared to the 1980s, the risk 
of CL associated with multiple birth was increased for chil-
dren born during the 1990s when MAR was gaining ground 
but not during the 2000s when it became even more common 
(Tables S12–S14), therefore providing no clear support for 
this hypothesis. If indeed such interventions explained the 
observed association in our study, the question arises, why 
recent large studies found no evidence of an increased risk 
among children of multiple births [16, 43], although some 
studies reported odds ratios above 1.2 for leukemias [20] or 
even higher in some age subgroups [36].
Regarding other perinatal characteristics our investiga-
tion was either compatible (maternal age) with or provided 
further support (birth weight) for expected associations [27, 
33]. Moreover, our study confirmed a recent report of an 
interaction adding an enhanced protective effect to later born 
children with low birth weight [39] that, due to the lack of 
data on gestational age and limited sample sizes, we could 
not explore fully but merits further investigation in future 
studies. A possible explanation offered by the authors of 
that study is that the compounded effect of the greater risk 
of infections that low birth weight babies have in early life 
together with the increased early exposure to infections that 
comes from having older siblings could result in a stronger 
immune response.
Conclusions
Our results add to the existing evidence that high birth 
weight is associated with an increased risk of childhood 
leukemia. Furthermore, our study is the first to report evi-
dence suggesting that children from multiple births are at 
increased risk for developing leukemia overall and ALL 
specifically.
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